ClinicalTrials.Veeva

Menu

The Effect of Infusion Pressure on the Outcomes of Phacoemulsification Surgery; the ENHANSE Study

S

South Tyneside and Sunderland NHS Foundation Trust

Status

Unknown

Conditions

Cataract

Treatments

Device: Centurion Phacoemulsification System

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The effect of infusion pressure on the outcomes of phacoemulsification surgery.

Full description

The Centurion phacoemulsification system with active sentry allows efficient cataract surgery with safe use of high vacuums, whilst allowing low and physiological infusion pressures, significantly lower than other surgical systems. There are reasons to expect that this will lead to patient benefit but it is uncertain if low infusion pressure during phacoemulsification will lead to improved outcomes. This is of particular interest in patients with vascular retinopathies such as diabetic retinopathy where the retinal vasculature is compromised, as well as glaucoma and other optic neuropathies where there is established nerve fibre layer loss.

The investigator will carry out a feasibility study with a two surgeon RCT of 70 patients with diabetic retinopathy and/or glaucoma undergoing phacoemulsification with randomisation of two different infusion pressures (low (30mmHg) versus the higher pressure (~70mmHg) as currently used) using the active sentry system with assessment of a range of exploratory endpoints.

Enrollment

70 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Patients with cataract undergoing routine phacoemulsification with either diabetic retinopathy or glaucoma of any degree

Exclusion criteria

  • Dense cataract precluding adequate retinal imaging
  • posterior polar cataract
  • subluxated cataract,
  • other vision affecting pathology,
  • severe glaucoma

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

70 participants in 2 patient groups

Standard pressure
Active Comparator group
Description:
Infusion pressures during phacoemulsification surgeon using the Alcon active sentry system with the Centurion - 70mmHg
Treatment:
Device: Centurion Phacoemulsification System
Low or physiological pressure
Active Comparator group
Description:
Infusion pressures during phacoemulsification surgeon using the Alcon active sentry system with the Centurion - 30mmHg
Treatment:
Device: Centurion Phacoemulsification System

Trial contacts and locations

0

Loading...

Central trial contact

David Steel; Steve Dodds

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems